Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study

Gómez-Reino Carnota, Juan Jesús
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/5751
PMID: 21736751
ISSN: 1471-2474
Full record
Services
Services
RISMendeleyLinksolver
Date issued
2011
Journal title
BMC MUSCULOSKELETAL DISORDERS
Type of content
Artigo